Simplex Trading’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-33,879
| Closed | -$5.72M | – | 9540 |
|
|
2025
Q4 | $5.72M | Buy |
+33,879
| New | +$5.5M | ﹤0.01% | 1182 |
|
|
2024
Q3 | – | Sell |
-3,901
| Closed | -$535K | – | 8946 |
|
|
2024
Q2 | $535K | Sell |
3,901
-1,271
| -25% | -$170K | ﹤0.01% | 3599 |
|
|
2024
Q1 | $709K | Buy |
+5,172
| New | +$706K | ﹤0.01% | 3480 |
|
|
2023
Q2 | – | Sell |
-42,162
| Closed | -$5.45M | – | 9390 |
|
|
2023
Q1 | $5.45M | Buy |
+42,162
| New | +$5.52M | ﹤0.01% | 1246 |
|
|
2022
Q3 | – | Sell |
-205
| Closed | -$24K | – | 10330 |
|
|
2022
Q2 | $24K | Sell |
205
-2,571
| -93% | -$305K | ﹤0.01% | 7395 |
|
|
2022
Q1 | $361K | Buy |
+2,776
| New | +$362K | ﹤0.01% | 4287 |
|
|
2020
Q3 | – | Sell |
-506
| Closed | -$69K | – | 8085 |
|
|
2020
Q2 | $69K | Sell |
506
-12,644
| -96% | -$1.61M | ﹤0.01% | 5182 |
|
|
2020
Q1 | $1.42M | Buy |
+13,150
| New | +$1.51M | ﹤0.01% | 1563 |
|
|
2019
Q4 | – | Sell |
-13,721
| Closed | -$1.36M | – | 7565 |
|
|
2019
Q3 | $1.36M | Buy |
+13,721
| New | +$1.44M | ﹤0.01% | 1661 |
|
|
2019
Q2 | – | Sell |
-23,113
| Closed | -$2.58M | – | 7400 |
|
|
2019
Q1 | $2.58M | Buy |
23,113
+14,892
| +181% | +$1.63M | 0.01% | 1145 |
|
|
2018
Q4 | $792K | Buy |
+8,221
| New | +$873K | ﹤0.01% | 1831 |
|
|
2018
Q2 | – | Sell |
-35,801
| Closed | -$3.82M | – | 7572 |
|
|
2018
Q1 | $3.82M | Buy |
+35,801
| New | +$3.97M | 0.17% | 109 |
|
|
2017
Q4 | – | Sell |
-34,680
| Closed | -$3.86M | – | 6272 |
|
|
2017
Q3 | $3.86M | Buy |
34,680
+20,496
| +145% | +$2.19M | 0.16% | 106 |
|
|
2017
Q2 | $1.47M | Buy |
14,184
+13,623
| +2,428% | +$1.34M | 0.06% | 249 |
|
|
2017
Q1 | $54K | Sell |
561
-84,222
| -99% | -$8.06M | ﹤0.01% | 2281 |
|
|
2016
Q4 | $7.5M | Buy |
84,783
+41,049
| +94% | +$3.74M | 0.45% | 32 |
|
|
2016
Q3 | $4.22M | Buy |
43,734
+16,134
| +58% | +$1.53M | 0.29% | 57 |
|
|
2016
Q2 | $2.37M | Sell |
27,600
-50,007
| -64% | -$4.49M | 0.16% | 117 |
|
|
2016
Q1 | $6.75M | Buy |
+77,607
| New | +$6.94M | 0.54% | 26 |
|
|
2015
Q4 | – | Sell |
-1,173
| Closed | -$118K | – | 5698 |
|
|
2015
Q3 | $118K | Buy |
+1,173
| New | +$141K | 0.01% | 1294 |
|
|
2015
Q2 | – | Sell |
-22,938
| Closed | -$2.63M | – | 5456 |
|
|
2015
Q1 | $2.63M | Buy |
+22,938
| New | +$2.53M | 0.31% | 63 |
|
Other funds holding IBB
CB
Simplex Trading's IBB Position: Q1 2026 in Review
Simplex Trading sold out of iShares Biotechnology ETF (IBB) in Q1 2026, closing a stake of 33,879 shares — an estimated $5.72M sold.
Simplex Trading first reported a position in IBB in Q1 2015 and held it in 21 quarters. The position peaked at $7.5M in Q4 2016. 923 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- Simplex Trading reported no remaining iShares Biotechnology ETF position as of Q1 2026 after selling out during the quarter.
- Simplex Trading sold 33,879 iShares Biotechnology ETF shares in Q1 2026, an estimated $5.72M.
- Simplex Trading first reported a position in iShares Biotechnology ETF in Q1 2015 and held it in 21 quarters.
- Simplex Trading's iShares Biotechnology ETF position peaked at $7.5M in Q4 2016.
- 923 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.